19.600
−9,68%
2025-02-21
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -25.9% | -5.3% | 1 / 3 | +1.8% | -0.76 pp | -0.02 pp | +0.5% | 0.45 | 209.31 | 6,7 | +1,8% | 0,0 | −25,9% | 209.31 | 286.50 | −26,9% |
| Pts | 0 | 0 | 4 | 0 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 19.600 (close price on 2025-02-21)EPS (TTM): 93,6
Financial charts
1.Revenue & growth
VND bn6,71Q2/26
1.Revenue & growth
VND bn6,71Q2/26
2.Profit & growth
VND bn-0,03Q2/26
3.Profit mix (Penman)
VND bn0,71Q2/26
4.Margins & cost structure
%21.8%Q2/26
5.Returns & cash cycle
% · days0.9%Q2/26
6.Earnings quality & cash
VND bn-15,6Q2/26
7.Asset structure
VND bn101Q2/26
8.Funding & debt health
VND bn · times101Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %273,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-20Q2/26
Adjusted EPS growth, latest quarter
-725%
Average adjusted EPS growth, 3 quarters
-238%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26